Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-03-28

Pages: 137 Pages

Report ld: 4669698

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Octreotide Market Size(US$)

CAGR 2025-2031

-2.8%

Market Size,2031

USD 2.3

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 2.8 million

Market Forecast in 2031(Value)

US$ 2.3 million

CAGR

-2.8%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.

Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Octreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Octreotide.

The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Octreotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Octreotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

By Company

Novartis

Sun Pharmaceutical

Chengdu Tiantaishan pharmaceutical

Sinopharm A-Think Pharmaceuticals

Sihuan Pharmaceutical Holdings Group

Shanghai Soho-Yiming Pharmaceuticals

Yibin Pharmaceutical

Segment by Type

Octreotide Injection

Octreotide Powder

Octreotide Microspheres

Segment by Application

Treating Severe Diarrhea

Treating Acromegaly

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Octreotide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Octreotide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Octreotide Product Introduction

1.2 Market by Type

1.2.1 Global Octreotide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Octreotide Injection

1.2.3 Octreotide Powder

1.2.4 Octreotide Microspheres

1.3 Market by Application

1.3.1 Global Octreotide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Treating Severe Diarrhea

1.3.3 Treating Acromegaly

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Octreotide Market Size Estimates and Forecasts

2.1.1 Global Octreotide Revenue 2020-2031

2.1.2 Global Octreotide Sales 2020-2031

2.2 Octreotide Market Size by Region: 2024 Versus 2031

2.3 Octreotide Sales by Region (2020-2031)

2.3.1 Global Octreotide Sales by Region: 2020-2025

2.3.2 Global Octreotide Sales Forecast by Region (2026-2031)

2.3.3 Global Octreotide Sales Market Share by Region (2020-2031)

2.4 Octreotide Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Octreotide Revenue by Region: 2020-2025

2.4.2 Global Octreotide Revenue Forecast by Region (2026-2031)

2.4.3 Global Octreotide Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Octreotide Sales by Type (2020-2031)

3.1.1.1 Global Octreotide Sales Volume by Type (2020-2031)

3.1.1.2 Global Octreotide Sales Market Share by Type (2020-2031)

3.1.2 Global Octreotide Revenue by Type (2020-2031)

3.1.2.1 Global Octreotide Revenue by Type (2020-2031)

3.1.2.2 Global Octreotide Revenue Market Share by Type (2020-2031)

3.1.3 Octreotide Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Octreotide Sales by Application (2020-2031)

3.2.1.1 Global Octreotide Sales Volume by Application (2020-2031)

3.2.1.2 Global Octreotide Sales Market Share by Application (2020-2031)

3.2.2 Global Octreotide Revenue by Application (2020-2031)

3.2.2.1 Global Octreotide Revenue by Application (2020-2031)

3.2.2.2 Global Octreotide Revenue Market Share by Application (2020-2031)

3.2.3 Octreotide Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Octreotide Injection of Octreotide Revenue Market Share by Application

3.3.2 Octreotide Powder of Octreotide Revenue Market Share by Application

3.3.3 Octreotide Microspheres of Octreotide Revenue Market Share by Application

4 Global Octreotide by Manufacturers

4.1 Global Top Octreotide Manufacturers by Sales (2020-2025)

4.1.1 Global Octreotide Sales by Manufacturer (2020-2025)

4.1.2 Global Octreotide Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Octreotide Manufacturers by Revenue (2020-2025)

4.2.1 Global Octreotide Revenue by Manufacturer (2020-2025)

4.2.2 Global Octreotide Revenue Share by Manufacturer (2020-2025)

4.3 Global Octreotide Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Octreotide Manufacturers Covered: Ranking by Revenue

4.4.2 Global Octreotide Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Octreotide Manufacturing Base Distribution, Product Type

4.5.1 Octreotide Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Octreotide Market

4.5.3 Manufacturers Octreotide Product Type and Application

4.5.4 Octreotide Injection Market Sales of Octreotide by Manufacturer

4.5.5 Octreotide Powder Market Sales of Octreotide by Manufacturer

4.5.6 Octreotide Microspheres Market Sales of Octreotide by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Novartis

5.1.1 Novartis Company Information

5.1.2 Novartis Description, Business Overview

5.1.3 Novartis Octreotide Products Offered

5.1.4 Novartis Octreotide Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Novartis Octreotide Sales by Product in 2024

5.1.6 Novartis Octreotide Sales by Application in 2024

5.1.7 Novartis Octreotide Sales by Geographic Area in 2024

5.1.8 Novartis Recent Developments

5.2 Sun Pharmaceutical

5.2.1 Sun Pharmaceutical Company Information

5.2.2 Sun Pharmaceutical Description, Business Overview

5.2.3 Sun Pharmaceutical Octreotide Products Offered

5.2.4 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Sun Pharmaceutical Octreotide Sales by Product in 2024

5.2.6 Sun Pharmaceutical Octreotide Sales by Application in 2024

5.2.7 Sun Pharmaceutical Octreotide Sales by Geographic Area in 2024

5.2.8 Sun Pharmaceutical Recent Developments

5.3 Chengdu Tiantaishan pharmaceutical

5.3.1 Chengdu Tiantaishan pharmaceutical Company Information

5.3.2 Chengdu Tiantaishan pharmaceutical Description, Business Overview

5.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Products Offered

5.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Product in 2024

5.3.6 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Application in 2024

5.3.7 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Geographic Area in 2024

5.3.8 Chengdu Tiantaishan pharmaceutical Recent Developments

5.4 Sinopharm A-Think Pharmaceuticals

5.4.1 Sinopharm A-Think Pharmaceuticals Company Information

5.4.2 Sinopharm A-Think Pharmaceuticals Description, Business Overview

5.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Products Offered

5.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Product in 2024

5.4.6 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Application in 2024

5.4.7 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Geographic Area in 2024

5.4.8 Sinopharm A-Think Pharmaceuticals Recent Developments

5.5 Sihuan Pharmaceutical Holdings Group

5.5.1 Sihuan Pharmaceutical Holdings Group Company Information

5.5.2 Sihuan Pharmaceutical Holdings Group Description, Business Overview

5.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Products Offered

5.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Product in 2024

5.5.6 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Application in 2024

5.5.7 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Geographic Area in 2024

5.5.8 Sihuan Pharmaceutical Holdings Group Recent Developments

5.6 Shanghai Soho-Yiming Pharmaceuticals

5.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information

5.6.2 Shanghai Soho-Yiming Pharmaceuticals Description, Business Overview

5.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Products Offered

5.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Product in 2024

5.6.6 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Application in 2024

5.6.7 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Geographic Area in 2024

5.6.8 Shanghai Soho-Yiming Pharmaceuticals Recent Developments

5.7 Yibin Pharmaceutical

5.7.1 Yibin Pharmaceutical Company Information

5.7.2 Yibin Pharmaceutical Description, Business Overview

5.7.3 Yibin Pharmaceutical Octreotide Products Offered

5.7.4 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Yibin Pharmaceutical Octreotide Sales by Product in 2024

5.7.6 Yibin Pharmaceutical Octreotide Sales by Application in 2024

5.7.7 Yibin Pharmaceutical Octreotide Sales by Geographic Area in 2024

5.7.8 Yibin Pharmaceutical Recent Developments

6 North America

6.1 North America Octreotide Market Size YoY Growth 2020-2031

6.2 North America Octreotide Market Facts & Figures by Country

6.2.1 North America Octreotide Sales by Country (2020-2031)

6.2.2 North America Octreotide Revenue by Country (2020-2031)

6.3 North America Octreotide Sales by Type (2020-2025)

6.4 North America Octreotide Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Octreotide Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Octreotide Market Facts & Figures by Region

7.2.1 Asia-Pacific Octreotide Sales by Region (2020-2031)

7.2.2 Asia-Pacific Octreotide Revenue by Region (2020-2031)

7.3 Asia-Pacific Octreotide Sales by Type (2020-2025)

7.4 Asia-Pacific Octreotide Sales by Application (2020-2025)

8 Europe

8.1 Europe Octreotide Market Size YoY Growth 2020-2031

8.2 Europe Octreotide Market Facts & Figures by Country

8.2.1 Europe Octreotide Sales by Country (2020-2031)

8.2.2 Europe Octreotide Revenue by Country (2020-2031)

8.3 Europe Octreotide Sales by Type (2020-2025)

8.4 Europe Octreotide Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Octreotide Market Size YoY Growth 2020-2031

9.2 Latin America Octreotide Market Facts & Figures by Country

9.2.1 Latin America Octreotide Sales by Country (2020-2031)

9.2.2 Latin America Octreotide Revenue by Country (2020-2031)

9.3 Latin America Octreotide Sales by Type (2020-2025)

9.4 Latin America Octreotide Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Octreotide Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Octreotide Market Facts & Figures by Country

10.2.1 Middle East and Africa Octreotide Sales by Country (2020-2031)

10.2.2 Middle East and Africa Octreotide Revenue by Country (2020-2031)

10.3 Middle East and Africa Octreotide Sales by Type (2020-2025)

10.4 Middle East and Africa Octreotide Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Octreotide Supply Chain Analysis

11.2 Octreotide Key Raw Materials and Upstream Suppliers

11.3 Octreotide Clients Analysis

11.4 Octreotide Sales Channel and Sales Model Analysis

11.4.1 Octreotide Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Octreotide Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Octreotide Distributors

12 Octreotide Market Dynamics

12.1 Octreotide Industry Trends

12.2 Octreotide Market Drivers

12.3 Octreotide Market Challenges

12.4 Octreotide Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Octreotide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Octreotide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Octreotide Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Octreotide Sales by Region (2020-2025) & (Gram)

Table 5. Global Octreotide Sales Forecast by Region (2026-2031) & (Gram)

Table 6. Global Octreotide Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Octreotide Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Octreotide Sales Volume by Type (2020-2025) & (Gram)

Table 9. Global Octreotide Sales Volume by Type (2026-2031) & (Gram)

Table 10. Global Octreotide Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Octreotide Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Octreotide Sales Volume by Application (2020-2025) & (Gram)

Table 13. Global Octreotide Sales Volume by Application (2026-2031) & (Gram)

Table 14. Global Octreotide Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Octreotide Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Octreotide Sales by Manufacturer (2020-2025) & (Gram)

Table 17. Global Octreotide Sales Share by Manufacturer (2020-2025)

Table 18. Octreotide Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Octreotide Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Octreotide Price (2020-2025) & (USD/Gram)

Table 21. Ranking of Global Top Octreotide Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Octreotide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Octreotide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide as of 2024)

Table 24. Octreotide Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Octreotide Market

Table 26. Manufacturers Octreotide Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Novartis Company Information

Table 29. Novartis Description and Business Overview

Table 30. Novartis Octreotide Product

Table 31. Novartis Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)

Table 32. Novartis Sales Proportion of Octreotide by Product in 2024

Table 33. Novartis Sales Proportion of Octreotide by Application in 2024

Table 34. Novartis Sales Proportion of Octreotide by Geographic Area in 2024

Table 35. Novartis Recent Developments

Table 36. Sun Pharmaceutical Company Information

Table 37. Sun Pharmaceutical Description and Business Overview

Table 38. Sun Pharmaceutical Octreotide Product

Table 39. Sun Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)

Table 40. Sun Pharmaceutical Sales Proportion of Octreotide by Product in 2024

Table 41. Sun Pharmaceutical Sales Proportion of Octreotide by Application in 2024

Table 42. Sun Pharmaceutical Sales Proportion of Octreotide by Geographic Area in 2024

Table 43. Sun Pharmaceutical Recent Developments

Table 44. Chengdu Tiantaishan pharmaceutical Company Information

Table 45. Chengdu Tiantaishan pharmaceutical Description and Business Overview

Table 46. Chengdu Tiantaishan pharmaceutical Octreotide Product

Table 47. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)

Table 48. Chengdu Tiantaishan pharmaceutical Sales Proportion of Octreotide by Product in 2024

Table 49. Chengdu Tiantaishan pharmaceutical Sales Proportion of Octreotide by Application in 2024

Table 50. Chengdu Tiantaishan pharmaceutical Sales Proportion of Octreotide by Geographic Area in 2024

Table 51. Chengdu Tiantaishan pharmaceutical Recent Developments

Table 52. Sinopharm A-Think Pharmaceuticals Company Information

Table 53. Sinopharm A-Think Pharmaceuticals Description and Business Overview

Table 54. Sinopharm A-Think Pharmaceuticals Octreotide Product

Table 55. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)

Table 56. Sinopharm A-Think Pharmaceuticals Sales Proportion of Octreotide by Product in 2024

Table 57. Sinopharm A-Think Pharmaceuticals Sales Proportion of Octreotide by Application in 2024

Table 58. Sinopharm A-Think Pharmaceuticals Sales Proportion of Octreotide by Geographic Area in 2024

Table 59. Sinopharm A-Think Pharmaceuticals Recent Developments

Table 60. Sihuan Pharmaceutical Holdings Group Company Information

Table 61. Sihuan Pharmaceutical Holdings Group Description and Business Overview

Table 62. Sihuan Pharmaceutical Holdings Group Octreotide Product

Table 63. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)

Table 64. Sihuan Pharmaceutical Holdings Group Sales Proportion of Octreotide by Product in 2024

Table 65. Sihuan Pharmaceutical Holdings Group Sales Proportion of Octreotide by Application in 2024

Table 66. Sihuan Pharmaceutical Holdings Group Sales Proportion of Octreotide by Geographic Area in 2024

Table 67. Sihuan Pharmaceutical Holdings Group Recent Developments

Table 68. Shanghai Soho-Yiming Pharmaceuticals Company Information

Table 69. Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview

Table 70. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product

Table 71. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)

Table 72. Shanghai Soho-Yiming Pharmaceuticals Sales Proportion of Octreotide by Product in 2024

Table 73. Shanghai Soho-Yiming Pharmaceuticals Sales Proportion of Octreotide by Application in 2024

Table 74. Shanghai Soho-Yiming Pharmaceuticals Sales Proportion of Octreotide by Geographic Area in 2024

Table 75. Shanghai Soho-Yiming Pharmaceuticals Recent Developments

Table 76. Yibin Pharmaceutical Company Information

Table 77. Yibin Pharmaceutical Description and Business Overview

Table 78. Yibin Pharmaceutical Octreotide Product

Table 79. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)

Table 80. Yibin Pharmaceutical Sales Proportion of Octreotide by Product in 2024

Table 81. Yibin Pharmaceutical Sales Proportion of Octreotide by Application in 2024

Table 82. Yibin Pharmaceutical Sales Proportion of Octreotide by Geographic Area in 2024

Table 83. Yibin Pharmaceutical Recent Developments

Table 84. North America Octreotide Sales by Country (2020-2025) & (Gram)

Table 85. North America Octreotide Sales by Country (2026-2031) & (Gram)

Table 86. North America Octreotide Revenue by Country (2020-2025) & (US$ Million)

Table 87. North America Octreotide Revenue by Country (2026-2031) & (US$ Million)

Table 88. North America Octreotide Sales by Type (2020-2025) & (Gram)

Table 89. North America Octreotide Sales by Application (2020-2025) & (Gram)

Table 90. Asia-Pacific Octreotide Sales by Region (2020-2025) & (Gram)

Table 91. Asia-Pacific Octreotide Sales by Region (2026-2031) & (Gram)

Table 92. Asia-Pacific Octreotide Revenue by Region (2020-2025) & (US$ Million)

Table 93. Asia-Pacific Octreotide Revenue by Region (2026-2031) & (US$ Million)

Table 94. Asia-Pacific Octreotide Sales by Type (2020-2025) & (Gram)

Table 95. Asia-Pacific Octreotide Sales by Application (2020-2025) & (Gram)

Table 96. Europe Octreotide Sales by Country (2020-2025) & (Gram)

Table 97. Europe Octreotide Sales by Country (2026-2031) & (Gram)

Table 98. Europe Octreotide Revenue by Country (2020-2025) & (US$ Million)

Table 99. Europe Octreotide Revenue by Country (2026-2031) & (US$ Million)

Table 100. Europe Octreotide Sales by Type (2020-2025) & (Gram)

Table 101. Europe Octreotide Sales by Application (2020-2025) & (Gram)

Table 102. Latin America Octreotide Sales by Country (2020-2025) & (Gram)

Table 103. Latin America Octreotide Sales by Country (2026-2031) & (Gram)

Table 104. Latin America Octreotide Revenue by Country (2020-2025) & (US$ Million)

Table 105. Latin America Octreotide Revenue by Country (2026-2031) & (US$ Million)

Table 106. Latin America Octreotide Sales by Type (2020-2025) & (Gram)

Table 107. Latin America Octreotide Sales by Application (2020-2025) & (Gram)

Table 108. Middle East and Africa Octreotide Sales by Country (2020-2025) & (Gram)

Table 109. Middle East and Africa Octreotide Sales by Country (2026-2031) & (Gram)

Table 110. Middle East and Africa Octreotide Revenue by Country (2020-2025) & (US$ Million)

Table 111. Middle East and Africa Octreotide Revenue by Country (2026-2031) & (US$ Million)

Table 112. Middle East and Africa Octreotide Sales by Type (2020-2025) & (Gram)

Table 113. Middle East and Africa Octreotide Sales by Application (2020-2025) & (Gram)

Table 114. Octreotide Key Raw Materials, Industry Status and Trend

Table 115. Octreotide Key Raw Materials and Upstream Suppliers

Table 116. Octreotide Clients Status and Trend

Table 117. Octreotide Typical Clients

Table 118. Octreotide Distributors

Table 119. Octreotide Market Trends

Table 120. Octreotide Market Drivers

Table 121. Octreotide Market Challenges

Table 122. Octreotide Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Octreotide Product Picture

Figure 2. Global Octreotide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Octreotide Sales Market Share by Type in 2024 & 2031

Figure 4. Octreotide Injection Product Picture

Figure 5. Octreotide Powder Product Picture

Figure 6. Octreotide Microspheres Product Picture

Figure 7. Global Octreotide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Octreotide Sales Market Share by Application in 2024 & 2031

Figure 9. Treating Severe Diarrhea

Figure 10. Treating Acromegaly

Figure 11. Others

Figure 12. Octreotide Report Years Considered

Figure 13. Global Octreotide Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Octreotide Market Size 2020-2031 (US$ Million)

Figure 15. Global Octreotide Sales 2020-2031 (Gram)

Figure 16. Global Octreotide Sales Market Share Forecast by Region (2020-2031)

Figure 17. Global Octreotide Revenue Market Share by Region (2020-2031)

Figure 18. Global Octreotide Sales Market Share Forecast by Type (2020-2031)

Figure 19. Global Octreotide Revenue Market Share Forecast by Type (2020-2031)

Figure 20. Octreotide Average Selling Price (ASP) by Type (2020-2025) & (USD/Gram)

Figure 21. Global Octreotide Sales Market Share Forecast by Application (2020-2031)

Figure 22. Global Octreotide Revenue Market Share Forecast by Application (2020-2031)

Figure 23. Octreotide Average Selling Price (ASP) by Application (2020-2025) & (USD/Gram)

Figure 24. Octreotide Injection of Octreotide Revenue Market Share by Application, 2024 VS 2031

Figure 25. Octreotide Powder of Octreotide Revenue Market Share by Application, 2024 VS 2031

Figure 26. Octreotide Microspheres of Octreotide Revenue Market Share by Application, 2024 VS 2031

Figure 27. Global Octreotide Sales Share by Manufacturer in 2024

Figure 28. Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 29. Octreotide Injection Market Sales Proportion by Manufacturer in 2024

Figure 30. Octreotide Powder Market Sales Proportion by Manufacturer in 2024

Figure 31. Octreotide Microspheres Market Sales Proportion by Manufacturer in 2024

Figure 32. North America Octreotide Revenue 2020-2031 (US$ Million)

Figure 33. North America Octreotide Sales Market Share by Type (2020-2025)

Figure 34. North America Octreotide Sales Market Share by Application (2020-2025)

Figure 35. Asia-Pacific Octreotide Revenue 2020-2031 (US$ Million)

Figure 36. Asia-Pacific Octreotide Sales Market Share by Region (2020-2031)

Figure 37. Asia-Pacific Octreotide Revenue Market Share by Region (2020-2031)

Figure 38. Asia-Pacific Octreotide Sales Market Share by Type (2020-2025)

Figure 39. Asia-Pacific Octreotide Sales Market Share by Application (2020-2025)

Figure 40. Europe Octreotide Revenue Growth Rate 2020-2031 (US$ Million)

Figure 41. Europe Octreotide Sales Market Share by Country (2020-2031)

Figure 42. Europe Octreotide Revenue Market Share by Country (2020-2031)

Figure 43. Europe Octreotide Sales Market Share by Type (2020-2025)

Figure 44. Europe Octreotide Sales Market Share by Application (2020-2025)

Figure 45. Latin America Octreotide Revenue Growth Rate 2020-2031 (US$ Million)

Figure 46. Latin America Octreotide Sales Market Share by Country (2020-2031)

Figure 47. Latin America Octreotide Revenue Market Share by Country (2020-2025)

Figure 48. Latin America Octreotide Sales Market Share by Type (2020-2025)

Figure 49. Latin America Octreotide Sales Market Share by Application (2020-2025)

Figure 50. Middle East and Africa Octreotide Revenue Growth Rate 2020-2031 (US$ Million)

Figure 51. Middle East and Africa Octreotide Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Octreotide Revenue Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Octreotide Sales Market Share by Type (2020-2025)

Figure 54. Middle East and Africa Octreotide Sales Market Share by Application (2020-2025)

Figure 55. Octreotide Supply Chain (Upstream and Downstream Market)

Figure 56. Global Production Market Share of Octreotide Raw Materials by Region in 2024

Figure 57. Octreotide Distribution Channels

Figure 58. Global Octreotide Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 59. Global Octreotide Percentage 2020-2031: Online Sales VS Offline Sales

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Octreotide in 2031? zhanKai

The global market size of Octreotide in 2031 was 2.3 Million USD.

What is the annual compound growth rate of the global Octreotide market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Octreotide market? shouQi

What was the global market size of Octreotide in 2025? shouQi

Related Reports

Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 132
USD 4900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 103
USD 3950.00
(Single User License)
Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published Date: 2025-01-16
Pages: 78
USD 2900.00
(Single User License)
Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-16
Pages: 126
USD 5900.00
(Single User License)
Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-07
Pages: 96
USD 4900.00
(Single User License)

Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)
Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00 (Single User License)
Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 132
USD 4900.00 (Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 103
USD 3950.00 (Single User License)
Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published: 2025-01-16
Pages: 78
USD 2900.00 (Single User License)
Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-16
Pages: 126
USD 5900.00 (Single User License)
Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-07
Pages: 96
USD 4900.00 (Single User License)